• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT INSULIN Back to Search Results
Catalog Number 08K41-27
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated architect insulin assay results for 3 patients.The customer provided the following data.The retest results were generated at another laboratory, test method/ platform is unknown): sample 1: initial 27 retest 14; sample 2: initial 30 retest 17; sample 3 initial 38 retest 9.There was no adverse impact to patient management reported.
 
Manufacturer Narrative
On (b)(6) 2016 the suspect medical device lot number was updated.This is documented.Further investigation of the customer issue included a review of the complaint text, in-house testing, a search for similar complaints, a batch record review and a review of labeling.Return material was not available from the customer.An accuracy testing protocol was executed; testing met the acceptance criteria and determined the reagent is performing acceptably.Tracking and trending did not identify an adverse trend for the lot in question.No issues were identified which would indicate a product deficiency from the batch record review.Labeling was reviewed and found to be adequate.Based on the available information no product deficiency and no malfunction of the architect insulin reagent, list (b)(4), lot 60121lp76, was identified.
 
Manufacturer Narrative
Correction to the evaluation summary previously documented.The device evaluation was reassessed and concluded that a malfunction occurred, therefore, the documentation of no malfunction is inaccurate.However, no systemic issue or product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN
Type of Device
INSULIN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key5736198
MDR Text Key47794959
Report Number1415939-2016-00068
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 05/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/20/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/21/2016
Device Catalogue Number08K41-27
Device Lot Number60151LP76
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-